REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 115 filers reported holding REVANCE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.94 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,185,429 | +257.2% | 713,638 | +688.3% | 0.02% | +325.0% |
| Q2 2023 | $2,291,264 | +105.5% | 90,528 | +119.4% | 0.00% | +100.0% |
| Q3 2022 | $1,115,000 | +378.5% | 41,253 | +144.7% | 0.00% | – |
| Q2 2022 | $233,000 | -90.3% | 16,858 | -86.2% | 0.00% | -100.0% |
| Q1 2022 | $2,391,000 | +147.5% | 122,598 | +99.8% | 0.01% | 0.0% |
| Q1 2019 | $966,000 | – | 61,350 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,415,689 | $86,106,000 | 6.66% |
| Evolutionary Tree Capital Management, LLC | 176,336 | $3,439,000 | 2.39% |
| Essex Woodlands Management, Inc. | 457,085 | $8,913,000 | 2.16% |
| HealthCor Management, L.P. | 1,423,425 | $27,757,000 | 1.85% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,112,325 | $21,690,000 | 0.86% |
| Waypoint Capital Advisors, LLC | 53,989 | $1,016,000 | 0.60% |
| Antara Capital LP | 679,600 | $13,252,000 | 0.40% |
| Rhenman & Partners Asset Management AB | 198,358 | $3,868,000 | 0.38% |
| Walleye Capital LLC | 505,701 | $9,861,000 | 0.26% |
| Polar Capital Holdings Plc | 2,456,497 | $47,902,000 | 0.22% |